Filing Flows › GSK (GSK) › Q3 2026 › vs Q3 2025
GSK (GSK) Q3 2026 vs Q3 2025 (year over year)
GSK's revenue rose $340M (+4%) from $8.5B in Q3 2025 to $8.9B in Q3 2026. Gross margin 73.1% against 73.6% (-0.5 pts).
GSK, Q3 2026: revenue $8.9B (+4% year over year), operating margin 23.9%, net earnings $1.5B, operating cash flow $3.1B. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 73.1% | 73.6% | -0.5 pts |
| Operating margin | 23.9% | 30.3% | -6.4 pts |
| Net margin | 17.4% | 23.6% | -6.2 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $8.9B | $8.5B | $340M | +4% |
| Gross profit | $6.5B | $6.3B | $208M | +3% |
| Cost of revenue | $2.4B | $2.3B | $132M | +6% |
| Operating profit | $2.1B | $2.6B | −$466M | -18% |
| Operating expenses | $4.4B | $3.7B | $674M | +18% |
| Pre-tax earnings | $1.9B | $2.5B | −$521M | -21% |
| Other expense, net | $192M | $137M | $55.0M | +40% |
| Net earnings | $1.5B | $2.0B | −$470M | -23% |
| Minority interests | $160M | $131M | $29.0M | +22% |
| Income tax | $232M | $312M | −$80.0M | -26% |
| Working capital & other | $1.6B | −$2.0B | $3.6B | — |
| Operating cash flow | $3.1B | $24.0M | $3.1B | 130× |
Questions
How much did GSK's revenue grow year over year in Q3 2026?
GSK's revenue rose $340M (+4%) from $8.5B in Q3 2025 to $8.9B in Q3 2026. Gross margin 73.1% against 73.6% (-0.5 pts).